Viewing nowKanaden Tablet 60 mg (Pimasartan Potassium Hydrate)
Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

MFDS item code 202402993 · Approved 2024.12.17 · Insurance code 694004410
Treatment of essential hypertension
Essential hypertension is one of the major diseases characterized by elevated blood pressure, and this drug is used to control blood pressure in essential hypertension.
⦁ Adults The recommended dose of this medication is 30 ~ 60 milligrams once daily, taken with or without food. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended to take the medication at the same time each day (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect after approximately 8 weeks ~ 12 weeks. ⦁ Older adults No initial dose adjustment is necessary for older adults aged 70 years or younger. For older adults over 70 years of age, an initial dose of 30 mg once daily of this medication is recommended. (See section 9. Administration to Older Adults under Precautions for Use.) ⦁ Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment with 30 milligrams once daily and do not exceed 60 milligrams per day. ⦁ Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medication should not be administered to patients with moderate to severe hepatic impairment (see sections 2. Patients Who Should Not Receive This Medication and 10. Administration to Patients with Hepatic Impairment under Precautions for Use). ⦁ Patients with reduced effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with reduced effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. (See section 3. Patients for Whom This Medication Should Be Used with Caution under Precautions for Use.)
⦁ Pediatric patients The safety and efficacy of this medication have not been established in pediatric and adolescent patients aged 18 years or younger.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be stopped immediately upon confirmation of pregnancy. Patients who are allergic to any of the components of this medication, pregnant or breastfeeding women, patients on kidney dialysis, those with severe liver impairment, patients with bile duct obstruction, and diabetic patients with certain kidney dysfunction should not take this medication. Patients with low blood volume or salt deficiency, patients with impaired kidney function, patients with renovascular hypertension, patients with aortic or mitral stenosis, and those with primary aldosteronism should be especially cautious when taking this medication. This medication can cause various side effects such as headache, dizziness, dyspepsia, itching, and erectile dysfunction, and serious renal issues or cardiovascular abnormalities have been reported rarely. There can be a risk of hypotension when starting treatment or increasing the dose, so blood pressure and electrolyte levels should be monitored regularly, and appropriate measures should be taken immediately if symptoms of hypotension occur. This medication can increase serum potassium levels, so potassium supplements or potassium-sparing diuretics should be used with caution, and serum potassium levels should be monitored closely. There may be interactions when taken in combination with other antihypertensives, lithium, nonsteroidal anti-inflammatory drugs (NSAIDs), etc., so it is essential to consult with healthcare professionals. This medication is not recommended for breastfeeding women, and caution should be exercised in children and in elderly patients aged over 65 as its safety and efficacy have not been fully confirmed in these groups. In case of overdose, hypotension and arrhythmia may occur, so if symptoms arise, immediate medical attention should be sought. Lastly, this medication should be stored out of the reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that blocks light. Additionally, it is important to maintain a temperature between 1 and 30 degrees Celsius while storing the medication to preserve its efficacy.
Yellow oval film-coated tablet with a score line on one side
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowFimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Fimasartan Potassium Trihydrate 132.02mg
Tablet · Prescription medication
Boryung Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Boryung Pharmaceuticals Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Korea Hyutex Pharmaceuticals Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
HanKook Hytex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.